Kamila Wojas‐Krawczyk

1.1k total citations
77 papers, 751 citations indexed

About

Kamila Wojas‐Krawczyk is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Kamila Wojas‐Krawczyk has authored 77 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 41 papers in Pulmonary and Respiratory Medicine and 17 papers in Molecular Biology. Recurrent topics in Kamila Wojas‐Krawczyk's work include Lung Cancer Treatments and Mutations (38 papers), Lung Cancer Research Studies (23 papers) and Cancer Immunotherapy and Biomarkers (21 papers). Kamila Wojas‐Krawczyk is often cited by papers focused on Lung Cancer Treatments and Mutations (38 papers), Lung Cancer Research Studies (23 papers) and Cancer Immunotherapy and Biomarkers (21 papers). Kamila Wojas‐Krawczyk collaborates with scholars based in Poland, United States and Sweden. Kamila Wojas‐Krawczyk's co-authors include Paweł Krawczyk, Janusz Milanowski, Ewa Kalinka‐Warzocha, Tomasz Kucharczyk, Marcin Nicoś, Anna Grenda, Jacek Roliński, Rodryg Ramlau, Jacek Tabarkiewicz and Radosław Mlak and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Kamila Wojas‐Krawczyk

72 papers receiving 742 citations

Peers

Kamila Wojas‐Krawczyk

ONCOL

PRM

IMMUN

Jianya Zhou China

Svasti Haricharan United States

Aimin Jiang China

Gayle Marshall United Kingdom

Haoran Feng China

Samuel A. Kerk United States

Shixin Xiang China

Jingshu Geng China

Kien Pham United States

Xiaolu Yu China

Jianya Zhou China

Kamila Wojas‐Krawczyk

391 ×1.0

ONCOL

376 ×1.2

PRM

364 ×1.7

90 ×0.6

IMMUN

189 ×1.5

Citations per year, relative to Kamila Wojas‐Krawczyk Kamila Wojas‐Krawczyk (= 1×) peers Jianya Zhou

Countries citing papers authored by Kamila Wojas‐Krawczyk

Since Specialization

Citations

This map shows the geographic impact of Kamila Wojas‐Krawczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamila Wojas‐Krawczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamila Wojas‐Krawczyk more than expected).

Fields of papers citing papers by Kamila Wojas‐Krawczyk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamila Wojas‐Krawczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamila Wojas‐Krawczyk. The network helps show where Kamila Wojas‐Krawczyk may publish in the future.

Co-authorship network of co-authors of Kamila Wojas‐Krawczyk

This figure shows the co-authorship network connecting the top 25 collaborators of Kamila Wojas‐Krawczyk. A scholar is included among the top collaborators of Kamila Wojas‐Krawczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamila Wojas‐Krawczyk. Kamila Wojas‐Krawczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Krawczyk, Paweł, Kamila Wojas‐Krawczyk, Andrzej Tysarowski, et al.. (2025). Effectiveness of First-Line Treatment with Anaplastic Lymphoma Kinase and ROS1 Protoncogene Inhibitors in Non-Small Cell Lung Cancer Patients—Real-World Evidence of Two Polish Cancer Centers. Cancers. 17(7). 1253–1253.

Krawczyk, Paweł, et al.. (2023). Efficacy of chemoimmunotherapy in a lung adenocarcinoma patient with mutations in the KRAS and STK11. Oncology in Clinical Practice. 19(3). 197–202.

Wojas‐Krawczyk, Kamila, et al.. (2022). Clinical Application Perspectives of Lung Cancers 3D Tumor Microenvironment Models for In Vitro Cultures. International Journal of Molecular Sciences. 23(4). 2261–2261. 7 indexed citations

Wojas‐Krawczyk, Kamila, et al.. (2022). Non-Small-Cell Lung Cancer Patients with Coexistence of High PD-L1 Expression and RET Fusion—Which Path Should We Follow? Case Reports and Literature Review. Journal of Clinical Medicine. 11(6). 1630–1630. 5 indexed citations

Wojas‐Krawczyk, Kamila, et al.. (2021). Two Complementarity Immunotherapeutics in Non-Small-Cell Lung Cancer Patients—Mechanism of Action and Future Concepts. Cancers. 13(11). 2836–2836. 3 indexed citations

Wojas‐Krawczyk, Kamila, et al.. (2021). Failure of Immunotherapy—The Molecular and Immunological Origin of Immunotherapy Resistance in Lung Cancer. International Journal of Molecular Sciences. 22(16). 9030–9030. 38 indexed citations

Krawczyk, Paweł, Anna Grenda, Kamila Wojas‐Krawczyk, et al.. (2021). Crizotinib efficacy in advanced non-squamous NSCLC patients with ALK or ROS1 rearrangement. Scientific Reports. 11(1). 20939–20939. 6 indexed citations

Płachno, Bartosz J., Maciej Strzemski, Sławomir Dresler, et al.. (2020). A Chemometry of Aldrovanda vesiculosa L. (Waterwheel, Droseraceae) Populations. Molecules. 26(1). 72–72. 7 indexed citations

Wojas‐Krawczyk, Kamila, et al.. (2020). Aptamers in Non-Small Cell Lung Cancer Treatment. Molecules. 25(14). 3138–3138. 12 indexed citations

10.

Wojas‐Krawczyk, Kamila & Tomasz Kubiatowski. (2020). Imperfect Predictors for Lung Cancer Immunotherapy—A Field for Further Research. Frontiers in Oncology. 10. 568174–568174. 10 indexed citations

11.

Nicoś, Marcin, Kamila Wojas‐Krawczyk, Paweł Krawczyk, et al.. (2019). Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma. Archives of Medical Science. 16(6). 1496–1500. 1 indexed citations

12.

Wojas‐Krawczyk, Kamila, Ewa Kalinka‐Warzocha, Marcin Nicoś, et al.. (2018). Analysis of KRAS, NRAS, BRAF, and PIK3CA mutations could predictmetastases in colorectal cancer: A preliminary study. Advances in Clinical and Experimental Medicine. 28(1). 67–73. 10 indexed citations

13.

Nicoś, Marcin, Paweł Krawczyk, Kamila Wojas‐Krawczyk, et al.. (2017). Evaluation of ALK gene rearrangement in central nervous system metastases of non-small-cell lung cancer using two-step RT-PCR technique. Clinical & Translational Oncology. 19(12). 1447–1453. 2 indexed citations

14.

Strzemski, Maciej, Kamil Wojnicki, Ireneusz Sowa, et al.. (2017). In Vitro Antiproliferative Activity of Extracts of Carlina acaulis subsp. caulescens and Carlina acanthifolia subsp. utzka. Frontiers in Pharmacology. 8. 371–371. 29 indexed citations

15.

Krawczyk, Paweł & Kamila Wojas‐Krawczyk. (2015). Monoclonal antibodies against immune checkpoints in immunotherapy of cancer patients. Oncology in Clinical Practice. 11(2). 76–86. 2 indexed citations

16.

Mlak, Radosław, Paweł Krawczyk, Rodryg Ramlau, et al.. (2013). Predictive value of ERCC1 and RRM1 gene single-nucleotide polymorphisms for first-line platinum- and gemcitabine-based chemotherapy in non-small cell lung cancer patients. Oncology Reports. 30(5). 2385–2398. 23 indexed citations

17.

Milanowski, Janusz, Beata Biernacka, Radosław Mlak, et al.. (2012). Predictive value of ERCC1 single-nucleotide polymorphism in patients receiving platinum-based chemotherapy for locally-advanced and advanced non-small cell lung cancer — a pilot study. SHILAP Revista de lepidopterología. 1 indexed citations

18.

Krawczyk, Paweł, Dariusz M. Kowalski, Kamila Wojas‐Krawczyk, Maciej Krzakowski, & Janusz Milanowski. (2011). TORAKOCHIRURGIA Do NSCLC patients become sensitive to second-line erlotinib treatment after previous radiotherapy?. 7(4). 411–414. 1 indexed citations

19.

Krawczyk, Paweł, et al.. (2009). Evident clinical response to erlotinib as third-line treatment in EGFR FISH (+) male smoker patient with adenocarcinoma of lung. American Journal of Case Reports. 10. 166–171. 1 indexed citations

20.

Krawczyk, Paweł, et al.. (2009). Phenotype of dendritic cells generated in the presence of non-small cell lung cancer antigens - preliminary report.. Folia Histochemica et Cytobiologica. 46(4). 465–70. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact